Janet Vergis
Vermögen: 6 Mio $ am 31.07.2026
Vermögen: 6 Mio $ am 31.07.2026
Ms. Janet S.
Vergis is an Independent Director at SGS SA, an Independent Director at Dentsply Sirona, Inc. and an Independent Director at Church & Dwight Co., Inc. She is on the Board of Directors at SGS SA, Dentsply Sirona France SAS, Dentsply Sirona, Inc., IMPAX Corp, Church & Dwight Co., Inc. and National Association of Corporate Directors.
Ms. Vergis was previously employed as an Independent Director by Teva Pharmaceutical Industries Ltd., an Independent Director by Amneal Pharmaceuticals, Inc. /NJ/, an Executive-in-Residence by Warburg Pincus LLC, a Chief Executive Officer by OraPharma, Inc., a President by ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC., a President by McNeil Pediatrics, a President by Ortho-mcneil Neurologics, Inc., a President by Janssen LP, a Principal by Janssen-Cilag Ltd., and a Founder by Nulatis Therapeutics, Inc. She also served on the board at MedDay Pharmaceuticals SA and Lumara Health, Inc. She received her undergraduate degree from The Pennsylvania State University and a graduate degree from The Pennsylvania State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.03.2026 | 73.697 ( 0,01 % ) | 3 Mio $ | 31.07.2026 | |
| 01.07.2026 | 21.188 ( 0,01 % ) | 2 Mio $ | 31.07.2026 | |
DENTSPLY SIRONA, INC. 0,03 % | 03.06.2026 | 67.324 ( 0,03 % ) | 900 122 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CHURCH & DWIGHT CO., INC. | Direktor/Vorstandsmitglied | 01.05.2014 |
| DENTSPLY SIRONA INC. | Direktor/Vorstandsmitglied | 25.09.2019 |
| SGS SA | Direktor/Vorstandsmitglied | 23.03.2021 |
Dentsply Sirona France SAS
Dentsply Sirona France SAS Medical SpecialtiesHealth Technology Provides endodontic treatments and restorations | Direktor/Vorstandsmitglied | 01.03.2021 |
IMPAX Corp
IMPAX Corp Miscellaneous Commercial ServicesCommercial Services Provides sales consulting and training services | Direktor/Vorstandsmitglied | 01.01.2015 |
National Association of Corporate Directors
National Association of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Operates non-profit organizations which provides essential resources that helps directors strength board leadership | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Direktor/Vorstandsmitglied | 28.05.2026 |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Direktor/Vorstandsmitglied | 01.01.2021 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 02.08.2019 |
| ░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 19 |
|---|---|
Church & Dwight Co., Inc.
Church & Dwight Co., Inc. Household/Personal CareConsumer Non-Durables Manufactures and wholesales household & personal care and specialty chemical products | Consumer Non-Durables |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Warburg Pincus LLC
Warburg Pincus LLC Investment ManagersFinance Warburg Pincus invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. | Finance |
OraPharma, Inc.
OraPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces drugs for oral diseases | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Janssen-Cilag Ltd.
Janssen-Cilag Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products and services | Health Technology |
Nulatis Therapeutics, Inc. | |
SGS SA
SGS SA Miscellaneous Commercial ServicesCommercial Services Provides testing, inspection and certification services | Commercial Services |
IMPAX Corp
IMPAX Corp Miscellaneous Commercial ServicesCommercial Services Provides sales consulting and training services | Commercial Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Association of Corporate Directors
National Association of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Operates non-profit organizations which provides essential resources that helps directors strength board leadership | Commercial Services |
Janssen LP
Janssen LP Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Health Technology |
Ortho-mcneil Neurologics, Inc. | |
Dentsply Sirona, Inc.
Dentsply Sirona, Inc. Medical SpecialtiesHealth Technology Designs, manufactures endodontic, restorative and preventive consumable products, implants & provides CAD/CAM solutions | Health Technology |
McNeil Pediatrics | |
Dentsply Sirona France SAS
Dentsply Sirona France SAS Medical SpecialtiesHealth Technology Provides endodontic treatments and restorations | Health Technology |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen